1,N⁶-Ethenoadenine - ≥95% , CAS No.13875-63-3

CAS: 13875-63-3 Cat. No.: E338733 Formula: C7H5N5 Molecular Weight: 159.15 Beilstein Registry Number: 1107778
AVAILABLE TO ORDER
GRADE & PURITY ≥95%
Synonyms
1-N6-ethenoadenine|1,N6-ETHYLENEADENINE|3H-IMIDAZO[2,1-I]PURINE|1H-Imidazo(2,1-i)purine|.EPSILON.-ADENINE|3H-imidazo[1,2-i]purine|imidazo[2,1-i]purine|3H-IMIDAZO(2,1-I)PURINE|epsilonA nucleobase|1H-imidazo[2,1-f]purine|1,N6-ETHENOADENINE|1H-imidazo[2,1-i]purine|ethenoadenine|1,N(6)-Ethenoadenine
Storage
Store at 2-8°C
Shipped In
Wet ice
★
Size
Germany (EU)
USA*
Price
Qty
1mg
E338733-1mg
Made to order · 8–12 wks
€483.24
2mg
E338733-2mg
Made to order · 8–12 wks
€768.73
5mg
E338733-5mg
Made to order · 8–12 wks
€1,429.95
Enter a quantity for the sizes you want to add.

Overview

1,N|6|-Ethenoadenine caused DNA mutations in translesion DNA synthesis systems and in cell culture systems. It is implicated in liver, colon and lung cancers.

Specifications

Synonyms
1-N6-ethenoadenine | 1,N6-ETHYLENEADENINE | 3H-IMIDAZO[2,1-I]PURINE | 1H-Imidazo(2,1-i)purine | .EPSILON.-ADENINE | 3H-imidazo[1,2-i]purine | imidazo[2,1-i]purine | 3H-IMIDAZO(2,1-I)PURINE | epsilonA nucleobase | 1H-imidazo[2,1-f]purine | 1,N6-ETHENOADENINE | 1H-imidazo[2,1-i]purine | ethenoadenine | 1,N(6)-Ethenoadenine
Specifications & Purity
≥95%
Storage
Store at 2-8°C
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Purity
≥95%
Names and Identifiers
SMILES
C1=CN2C=NC3=C(C2=N1)NC=N3
IUPAC Name
1H-imidazo[2,1-f]purine
InChIKey
OGVOXGPIHFKUGM-UHFFFAOYSA-N
InChI
1S/C7H5N5/c1-2-12-4-11-6-5(7(12)8-1)9-3-10-6/h1-4H,(H,9,10)
Isomeric SMILES
C1=CN2C=NC3=C(C2=N1)NC=N3
WGK Germany
3
Molecular Weight
159.15
Beilstein
1107778
Reaxys
26025867
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=26025867&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassImidazopyrimidines
SubclassPurines and purine derivatives
Intermediate Tree Nodes Not available
Direct ParentPurines and purine derivatives
Alternative Parents Pyrimidines and pyrimidine derivatives  N-substituted imidazoles  Heteroaromatic compounds  Azacyclic compounds  Organopnictogen compounds  Organonitrogen compounds  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Purine - Pyrimidine - N-substituted imidazole - Heteroaromatic compound - Imidazole - Azole - Azacycle - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organonitrogen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as purines and purine derivatives. These are aromatic heterocyclic compounds containing a purine moiety, which is formed a pyrimidine-ring ring fused to an imidazole ring.
External Descriptors a small molecule
3D Structure
Interactive Chemical Structure Model





Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilitySoluble in water (partly).
Refractive Indexn20D1.96 (Predicted)
Boil Point439.81° C (Predicted)
Melt Point181.50° C (Predicted)
Molecular Weight159.15
XLogP31.000
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass159.054 Da
Monoisotopic Mass159.054 Da
Topological Polar Surface Area58.900 Ų
Heavy Atom Count12
Formal Charge0
Complexity185.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Safety and Hazards(GHS)
Precautionary Statements

P264:Wash hands [and …] thoroughly after handling.

WGK Germany
3
Reaxys
26025867
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=26025867&ln=
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No application protocols are specified in the Product Data for this item.

Guidance

  • For detailed, validated procedures (e.g., fluorescence assays, nucleoside synthesis, LC‑MS reference standard preparation), consult peer‑reviewed literature and adapt to your instrumentation and quality system. Verify performance with small‑scale pilots and appropriate controls.
Biological Roles

General/literature context (no clinical claims)

  • Lesion analog: 1,N6‑Ethenoadenine (εA) models a class of exocyclic DNA adducts formed when adenine reacts with electrophilic aldehydes (e.g., chloroacetaldehyde) originating from lipid peroxidation and xenobiotic metabolism. As an isolated base, εA is used to study lesion properties without the complexity of full nucleosides/oligonucleotides.

  • Recognition by repair enzymes: In vitro, εA‑containing nucleosides/oligos are known substrates for certain base‑excision repair glycosylases in bacteria and eukaryotes. Researchers use the free base to derive nucleosides and to benchmark binding and catalysis via fluorescence readouts (literature).

  • Biophysical reporter: The etheno bridge imparts strong, environment‑sensitive fluorescence. Changes in emission intensity and wavelength can report on base stacking, solvent polarity, and protonation state, enabling mechanistic studies of nucleic acid–protein interactions.

  • Tautomer/protonation effects: Protonation state influences hydrogen‑bonding patterns relative to native adenine, altering base‑pairing preferences in model systems. This is exploited to interrogate polymerase selectivity and mismatch processing using εA‑modified substrates (literature).

  • Metabolic fate (research context): As a modified base standard, εA helps validate analytical workflows for detecting etheno adducts in complex matrices. The free base is typically processed in vitro into nucleosides or oligonucleotides for biochemical experiments.

Buffer Applications

This compound is not a buffering agent and is not typically used to prepare buffer systems. However, buffer choice strongly affects its solubility and spectroscopic behavior.

  • Practical guidance (general)

    • Use low‑ionic‑strength buffers (e.g., 10–50 mM phosphate, acetate, or citrate) to minimize background absorbance/fluorescence.
    • pH control: Slightly acidic buffers (pH 5–6.5) or slightly basic (pH 8–9) can improve solubility via controlled protonation/deprotonation; verify stability by test scans.
    • Avoid amines (e.g., Tris) if conducting LC‑MS, as they may suppress ionization and can interact with ring nitrogens, altering spectra.
    • Filter and degas buffers for consistent fluorescence measurements; consider matching refractive index for comparative spectroscopy.
  • Recipes and exact buffering ranges are application‑dependent; no item‑specific buffer instructions are provided in the Product Data.

Green Alternatives

While 1,N6‑ethenoadenine itself is a solid reagent, greener choices focus on solvents and auxiliaries used with it.

  • Prefer aqueous and bio‑based solvents when feasible

    • Aqueous buffers (adjusted pH) often dissolve εA sufficiently for spectroscopy and biochemical assays, avoiding dipolar aprotics.
    • Ethanol (bio‑derived) can substitute for methanol/DMF in some preparations and spectroscopic measurements.
  • Reduce or replace dipolar aprotics

    • DMSO vs DMF/NMP: DMSO is generally less hazardous and has favorable EHS profiles relative to DMF/NMP; still, minimize quantity and facilitate recovery.
  • Greener glycosylation strategies (literature examples)

    • Use of catalytic Lewis acids in greener solvents (e.g., MeCN or 2‑MeTHF) instead of dichloroethane/chloroform when compatible.
    • Solvent‑free or microwave‑assisted silylation with HMDS/BSA has been reported to reduce solvent volumes.
  • Small comparison (general)

    • Water/Buffer: Lowest hazard, but limited solubility window; ideal for assays.
    • Ethanol: Renewable, lower toxicity; moderate solubility, good for UV/fluorescence baselines.
    • DMSO: High solvency; acceptable but persistent—plan for waste segregation.
    • DMF/NMP: Avoid where possible due to reproductive toxicity concerns; reserve for cases requiring maximum polarity.
  • Operational steps

    • Scale down stock concentrations to minimize solvent burden.
    • Use closed‑loop solvent recovery for MeCN/EtOH.
    • Implement HPLC methods favoring aqueous‑rich mobile phases and volatile buffers for easier solvent management.
Pharmaceutical Uses

No therapeutic or clinical uses are claimed or implied for this product. Research use only (per Product Data).

Relevant formulation/manufacturing contexts (general)

  • Analytical reference standard: εA can serve as a system suitability or identification standard for impurity profiling of etheno adducts in drug substance/drug product stability studies (e.g., LC/LC‑MS methods), when appropriate.
  • Process chemistry probes: As a model heteroaromatic base, εA may be used to evaluate extraction and purification protocols for purine‑like impurities during API manufacturing.
  • Fluorescent marker in process analytics: Its intrinsic fluorescence can aid in preliminary method scouting (e.g., fluorescence HPLC detection) to develop sensitive assays for related substances; confirm suitability with validation.

Regulatory/compendial status

  • No pharmacopeial monograph is indicated in the Product Data. If compendial use is intended, qualify against internal specifications and method validation criteria.

Handling notes for regulated settings

  • Establish impurity limits, identification thresholds, and system suitability criteria using qualified reference materials.
  • Maintain chain of custody and storage logs (2–8°C) to ensure standard integrity over time.
Physical Properties

Item-specific specs (from Product Data)

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Literature/general properties (for context only; not item specifications)

  • Phase: Solid nucleobase analog; typically off‑white to light tan (literature, varies with purity and hydration).
  • Solubility: Slightly soluble in water at neutral pH; solubility increases in mildly acidic (e.g., dilute HCl) or basic media due to protonation/deprotonation of ring nitrogens; readily soluble in polar aprotic solvents such as DMSO and DMF (literature).
  • Acid–base behavior: Multiple basic nitrogens; protonation at ring nitrogens under acidic conditions enhances aqueous solubility (literature). Exact pKa values for specific sites vary among reports; consult primary literature if pH‑dependent studies are critical.
  • UV/Fluorescence: Intrinsic fluorescence attributed to the etheno bridge; typical excitation in the near‑UV (≈300–340 nm) with emission in the violet region (≈400–420 nm) depending on solvent and pH (literature; verify under your conditions).
  • Hygroscopicity: Not strongly hygroscopic, but can adsorb moisture; store tightly closed (general handling guidance).

Not provided for this item (use CoA/Spec Sheet if needed):

  • Melting point, boiling point, density, logP, refractive index, water content, and trace impurity/metal limits: Not specified for this item; refer to CoA/Spec Sheet.
Quality & Grades
  • Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

  • How to interpret common grades for nucleobase analogs (general guidance)

    • Research grade: Suitable for most biochemical and synthetic applications; typical control of organic volatile impurities and residual inorganic salts; UV trace may be reported.
    • High‑purity/≥98%: Favored for fluorescence studies and kinetic assays to minimize background fluorescence and side reactions.
    • HPLC grade (when applied to solids/standards): Indicates low UV‑absorbing impurities by chromatography; supports analytical and bioanalytical method development.
    • Reference standard grade: Accompanied by detailed purity assay (qNMR/HPLC), water/volatile content, and impurity profiling—important for quantitative LC/GC/MS.
  • Stabilizers and additives

    • None stated in Product Data. If a stabilizer is present in a specific lot, it will be disclosed on the CoA; absence of disclosure generally implies neat solid.
  • What to check on receipt

    • CoA confirmation of identity (NMR/HRMS/LC), assay, and residual solvent levels.
    • Fluorescence/UV trace consistency with literature under matched solvent/pH.
    • For analytical standards: request uncertainty statements and traceability where applicable.
  • Lot-to-lot considerations

    • Minor color variation can occur without affecting performance; rely on chromatographic purity and spectral identity for acceptance.
Reaction & Applications

Applications (research use only)

  • Fluorescent nucleobase analog: εA is intrinsically fluorescent, enabling monitoring of base–stacking, microenvironment polarity, and binding to proteins/nucleic acids in vitro (literature). Commonly used as a lesion mimic in DNA/RNA models.
  • DNA damage/repair studies: Serves as a stable analog of etheno adducts formed from lipid peroxidation–derived aldehydes; used to probe recognition by base‑excision repair glycosylases in biochemical assays (literature; no clinical claims).
  • Analytical reference: Utilized as a qualitative/quantitative reference for LC/LC‑MS methods detecting etheno‑adducts and their precursors.

Synthetic chemistry roles (general)

  • Nucleoside synthesis: Acts as a base for N9‑glycosylation to furnish 1,N6‑ethenoadenosine analogs. Typical approaches include:
    • Vorbrüggen glycosylation: Silylation (e.g., HMDS or BSA) followed by activation with TMSOTf or SnCl4 and coupling to per‑acylated ribose/deoxyribose donors in MeCN or DCE.
    • Phase‑transfer or metal‑assisted glycosylations under milder conditions for sensitive sugar donors.
  • Derivatization: Electrophilic substitution at suitable ring positions is attenuated; however, N‑oxidation and protection/deprotection of ring nitrogens can be used to tune reactivity for selective functionalization (literature).

Practical notes

  • Drying: For glycosylation, ensure anhydrous conditions; pre‑dry under high vacuum at ambient temperature, then silylate in situ.
  • Fluorescence in reactions: Track reaction progress or purity by fluorescence‑assisted TLC/UPLC with near‑UV excitation, recognizing matrix‑dependent shifts in emission.
Reaction Conditions

General literature guidance (not item specifications)

  • Vorbrüggen glycosylation to εA nucleosides

    • Pre‑activation: Silylate εA with HMDS (neat or in toluene/MeCN) using catalytic ammonium sulfate or chlorotrimethylsilane; 50–80°C, 1–4 h, until homogeneous.
    • Coupling: Add per‑acylated sugar donor in MeCN or 1,2‑dichloroethane; activate with TMSOTf (0.5–1.5 equiv) or SnCl4 at 0–25°C; react 1–6 h. Typical isolated yields for well‑matched donors: 40–75% (literature range; depends on donor/protecting groups).
    • Workup: Quench with saturated NaHCO3 or pyridine; extract and purify by silica gel or reverse‑phase chromatography, monitoring by UV/fluorescence.
  • Salt formation/crystallization

    • Dissolve εA in minimal alcohol or acetonitrile; treat with dry HCl in ether or alcohol to precipitate the hydrochloride salt (0–5°C). Optimize stoichiometry to avoid over‑protonation.
  • Spectroscopic assays

    • Prepare 10–100 µM solutions in buffered aqueous/MeOH (pH 5.5–7.5) to record excitation/emission scans. Expect excitation in the 300–340 nm region and emission near 400–420 nm, with solvent/pH‑dependent shifts.
  • Stability considerations

    • Avoid prolonged heating in strong acid/base. For synthetic steps, maintain anhydrous conditions and neutralize carefully to prevent degradation.

Note: Exact conditions vary with substrate, protecting groups, and scale; consult primary literature and perform small‑scale optimization.

Safety & Handling

Authoritative safety information must be taken from the SDS. The following reflects available product data and general best practices.

  • Product Data hazard fields

    • Signal Word: Not specified for this item; refer to SDS.
    • H‑Statements: Not specified for this item; refer to SDS.
    • GHS Classification/Pictograms: Not specified for this item; refer to SDS.
  • General laboratory precautions (best practice)

    • PPE: Wear lab coat, safety glasses, and suitable chemical‑resistant gloves. Handle powders in a fume hood or ventilated enclosure to minimize dust inhalation.
    • Avoid: Inhalation of dust, ingestion, skin/eye contact. Prevent aerosolization during weighing and solution prep.
    • First aid (overview; defer to SDS): If inhaled—move to fresh air; if on skin—wash with soap and water; if in eyes—rinse cautiously with water; if swallowed—rinse mouth. Seek medical advice if persistent irritation occurs.
    • Fire/thermal decomposition: Organic nitrogenous solids can produce NOx and carbon oxides upon combustion. Use water spray, CO2, dry chemical, or foam as appropriate to surroundings.
    • Incompatibilities (general): Strong oxidizers; strong acids/bases may cause decomposition if concentrated or heated. For solution work, adjust pH gradually and avoid prolonged exposure to strong reagents.
    • Environmental: Avoid release to the environment. Collect spills with inert absorbent; dispose of according to institutional and local regulations.
  • Storage and transport

    • Storage Conditions (Product Data): Store at 2–8°C.
    • Shipped In (Product Data): Wet ice.
    • Keep container tightly closed; protect from light and moisture to preserve fluorescence characteristics.
Solvent Selection

Fit‑for‑purpose solvent choice for 1,N6‑ethenoadenine (general, literature‑based):

  • Polarity and hydrogen bonding

    • A polar, heteroatom‑rich base; benefits from hydrogen‑bonding solvents or ionization for dissolution.
  • Aqueous systems

    • Water (neutral): Limited solubility; may be insufficient for stock solutions.
    • Acidified water (e.g., 1–10 mM HCl) or buffered solutions below neutral pH increase solubility by protonating ring nitrogens.
    • Basic aqueous media (e.g., ≤10 mM NaOH) can also enhance solubility via deprotonation, but monitor for base‑promoted degradation at elevated temperature.
  • Organic solvents

    • DMSO, DMF, and NMP: Excellent solvents for preparing concentrated stock solutions for fluorescence or biochemical assays; dilute into aqueous buffers as needed (watch for precipitation upon dilution).
    • Alcohols (MeOH, EtOH): Moderate solubility; useful for UV/fluorescence spectroscopy and intermediate polarity systems.
    • Acetonitrile: Useful for HPLC method development and as a glycosylation medium (with silylated base) in synthesis.
  • Practical tips

    • Prepare a small DMSO or MeOH concentrate (e.g., 10–50 mM), then titrate into buffer with vigorous mixing to avoid local supersaturation.
    • Filter through 0.22 µm PTFE/NYLON if particulate remains; avoid cellulose acetate if working in strong organic.
  • Comparison snapshot (general)

    • DMSO: highest solvating power; can quench some fluorescence at high fractions.
    • MeOH/EtOH: lower toxicity than DMF; good for spectroscopic baselines.
    • Water (acidified): preferred for bioassays to minimize organic cosolvent effects.
Storage & Reconstitution
  • Storage (Product Data)

    • Store at 2–8°C.
    • Shipped on wet ice to maintain recommended temperature during transit.
  • Container/handling

    • Keep tightly closed in a dry atmosphere. Protect from light and moisture to preserve spectral properties.
  • Reconstitution (general guidance; not item‑specific specifications)

    • For spectroscopic work: Dissolve in DMSO, MeOH, or acidified water to prepare a concentrated stock; then dilute into the working buffer while mixing to avoid precipitation. Filter if needed (0.22 µm).
    • For synthesis: Dry material under vacuum before silylation or other anhydrous steps. Use freshly dried solvents.
  • Stability after preparation (general)

    • Aqueous stocks are best prepared fresh. If storage is necessary, aliquot and keep at 2–8°C for short term or at −20°C for longer term; minimize freeze–thaw cycles. Monitor by HPLC/UV–vis for degradation.
  • Disposal

    • Dispose of unused solutions and waste according to institutional guidelines for organic nitrogenous compounds.

Note: Where exact solubility, concentration limits, or shelf‑life are critical, establish them empirically for your system or consult the lot‑specific CoA.

Structure & Identity

Brief overview: 1,N6‑Ethenoadenine (εA) is a fluorescent, etheno‑bridged purine base derived from adenine; it is widely used as a nucleobase analog and DNA damage lesion mimic in biochemical research.

  • Item-specific identifiers (from Product Data)

    • SKU: E338733
    • CAS: 13875-63-3
    • InChIKey: 257636 (note: provided key appears non-standard; verify on CoA/SDS)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature description)

    • Core scaffold: Purine analog with a fused imidazole–pyrimidine framework, like adenine.
    • Etheno bridge: An extra two‑carbon “etheno” moiety links N1 and N6 of adenine, forming a bicyclic bridge across the 6‑amino group, yielding a rigid, conjugated system.
    • Functional groups: Exocyclic imine/amide‑like N6 within the etheno bridge; ring nitrogens capable of hydrogen bonding and protonation; multiple π‑donor/acceptor sites.
    • Tautomerism: Purine‑like tautomeric equilibria are possible; the etheno bridge biases protonation and base‑pairing properties.
  • 2D structure in words (general)

    • A bicyclic purine nucleus bearing an intramolecular vinyl bridge between N1 (imidazole ring nitrogen) and N6 (exocyclic amine position of adenine), producing a condensed tricyclic appearance and extended conjugation responsible for intrinsic fluorescence.
Synthetic Utility

Functional profile (general)

  • N‑rich heteroaromatic base with constrained etheno bridge; electron distribution differs from adenine, influencing site selectivity for N‑glycosylation and protonation.

Key transformations (literature)

  • N9‑Glycosylation: Formation of εA nucleosides via Vorbrüggen conditions. Typical sequence: dry εA, silylate (HMDS/BSA, catalytic TMSCl or ammonium sulfate), couple with per‑acylated ribofuranose/deoxyribofuranose donors under TMSOTf or SnCl4 in MeCN/DCE; deprotect with MeONa/MeOH or ammonolysis.
  • Protection strategies: Transient N‑oxides or silyl protections can modulate reactivity and solubility; selective protection/deprotection guides downstream functionalization.
  • Salt formation: Protonation to give crystalline salts (e.g., hydrochlorides) can aid isolation, purification, or selective reactivity.
  • Late‑stage tagging: The persistent fluorescence enables tracking during purification (TLC/HPLC with fluorescence detection), facilitating impurity mapping and kinetics.

Retrosynthetic value

  • εA serves as a convergent node: derive from adenine via etheno annulation (e.g., chloroacetaldehyde cycloaddition—literature route) or elaborate into nucleosides/oligonucleotides. Its rigid scaffold provides a handle to interrogate structure–function in nucleic acid chemistry.

Practical notes

  • Ensure anhydrous handling before Lewis‑acid‑mediated couplings; residual water suppresses silylation and lowers yields.
  • Use buffered workups to prevent ring opening or hydrolysis under strongly basic or acidic conditions at elevated temperature.
Target Specificity

Not applicable. This product is a small‑molecule nucleobase analog, not a biological targeting reagent or antibody. No antigen/epitope, species reactivity, clone, or isotype information applies.

Frequently Asked Questions

What is the purity of this product?
This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at 2–8 °C. Refrigerated storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 13875-63-3, the molecular formula is C7H5N5, and the molecular weight is 159.15 g/mol. InChIKey OGVOXGPIHFKUGM-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.